BridgeBio Pharma, Inc. ( BBIO ) is a commercial-stage biotechnology company that delivers Acoramidis, indicated for ATTR-CM. The drug is called Attruby in the US and marketed as Beyonttra in the EU and Japan. Beyonttra is commercialized by Bayer (My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate degree in Business ...